Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanosha Investments is a private family office and investment vehicle rather than an operating life sciences, biotech, pharma, or healthcare company. Publicly available information indicates it has participated in investments touching healthcare and medtech, including Sparta Biomedical, but there is no evidence that Nanosha itself develops therapeutic products, operates a clinical pipeline, or markets healthcare services. The entity appears to function primarily as an investor and holder of private and public securities. Based on the available evidence, it should not be classified as a biotech or healthcare operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanosha Investments.